Huimin Kong
Papers
1
Total Citations
2
H-Index
1
About
Huimin Kong is a leading researcher at the intersection of nanomedicine and gene editing, with a primary focus on developing advanced nanotheranostic platforms for combating viral hepatitis and hepatocellular carcinoma. Her most notable contribution is the pioneering work on CRISPR/Cas-based nanotheranostics, where she and her colleagues conceptualized nanoscale CRISPR/Cas systems as "smart enzymatic robots" capable of precisely targeting and treating liver diseases. This work, published in *Advanced Science* in 2021, has garnered significant attention, laying the groundwork for integrating CRISPR technology with nanoparticle delivery systems to achieve both diagnosis and therapy in a single platform. Kong’s research addresses critical challenges in treating viral hepatitis and liver cancer, offering a transformative approach that combines the precision of gene editing with the versatility of nanomedicine. Her innovative contributions have been recognized in the scientific community, with her most-cited paper serving as a cornerstone for future developments in CRISPR nanotheranostics. Through her work, Kong is helping to pave the way for next-generation, intelligent therapeutic strategies that could revolutionize the management of complex liver diseases.
Research Focus
Key Achievements
Top Papers
- 1